Acute Effects of an Herbal Tea on Immune Surveillance and Activation.
1 other identifier
interventional
12
1 country
1
Brief Summary
A small cross-over trial on 24 people involving an herbal tea blend to test whether consuming 1 cup of tea triggers changes in the numbers of natural killer cells in the blood circulation as evidence of immune cell trafficking within 2 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2020
CompletedStudy Start
First participant enrolled
July 27, 2020
CompletedFirst Posted
Study publicly available on registry
July 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2021
CompletedSeptember 27, 2022
June 1, 2022
1.2 years
July 26, 2020
September 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change to natural killer cell numbers in blood circulation
Flow cytometry evaluation of natural killer cell numbers
Changes at 1 and 2 hours after consumption
Secondary Outcomes (1)
Change to natural killer cell activation status
Changes at 1 and 2 hours after consumption
Study Arms (2)
Herbal tea blend
ACTIVE COMPARATOR1 cup of herbal tea blend containing Rosehip and other berry extracts.
Warm water
SHAM COMPARATOR1 cup of warm water.
Interventions
1 cup of freshly brewed tea from an herbal tea blend.
Eligibility Criteria
You may qualify if:
- Healthy adults;
- Age 18-75 years (inclusive);
- Veins easy to see in both arms (to allow for the multiple blood draws);
- Willing to comply with a 24-hour wash-out period for vitamins and nutritional supplements;
You may not qualify if:
- Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder);
- Taking anti-inflammatory medications on a daily basis;
- Currently experiencing intense stressful events/ life changes;
- Currently in intensive athletic training (such as marathon runners);
- Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel;
- Actively depressed;
- An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);
- Unwilling to maintain a constant intake of supplements over the duration of the study;
- Anxiety about having blood drawn;
- Women of childbearing potential: Pregnant, nursing, or trying to become pregnant;
- Known food allergies related to ingredients in active test product.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gitte Jensen
Klamath Falls, Oregon, 97601-5904, United States
Study Officials
- STUDY DIRECTOR
GITTE JENSEN
NIS Labs
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2020
First Posted
July 29, 2020
Study Start
July 27, 2020
Primary Completion
October 25, 2021
Study Completion
December 19, 2021
Last Updated
September 27, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share